| Metric | შპს ნიუ ფარმა NEW PHARMA | სს ნიკორა |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾1.30bn₾1.01bn |
| Revenue growth | -100.0% | 27.9% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾140.4m₾116.9m |
| EBITDA margin | -29687.2%-11.6% | 10.8%11.5% |
| Net profit | -₾258k-₾726k | ₾62.4m₾69.0m |
| Net margin | -29249.2%-17.7% | 4.8%6.8% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾678.5m₾538.8m |
| Total equity | -₾780k-₾522k | ₾199.2m₾130.0m |
| ROE | — | 31.3%53.1% |